Completed PHASE4 INTERVENTIONAL 2-arm NCT02643433

Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines (MR+JE)

Immunogenicity of Co-administration of Measles Containing Vaccine and Japanese Encephalitis Alive Vaccines

Sponsor: Centers for Disease Control and Prevention

Conditions Japanese Encephalitis Measles Rubella

Interventions Japanese Encephalitis alive vaccine(JE) Measles-Rubella combined vaccine(MR)

Updated 5 times since 2017 Last updated: Jul 29, 2016 Started: Aug 31, 2015 Primary completion: Jun 30, 2016 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Japanese Encephalitis and Measles, this trial is completed. The trial is conducted by Centers for Disease Control and Prevention and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Centers for Disease Control and Prevention, China
Hubei Provincial Center for Disease Control and Prevention
Zhejiang Provincial Center for Disease Control and Prevention

Data source: Centers for Disease Control and Prevention, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hangzhou, China
• Shijiazhuang, China